Related Experiment Video
Updated: Apr 6, 2026
10:38
In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver
Published on: May 4, 2016
16.3K
NIEHS/FDA CLARITY-BPA research program update.
Jerrold J Heindel1, Retha R Newbold2, John R Bucher2
1National Institute of Environmental Health Sciences/National Institutes of Health, Division of Extramural Research and Training, Research Triangle Park, NC 27709, United States.
Reproductive Toxicology (Elmsford, N.Y.)
|August 2, 2015
Summary
Bisphenol A (BPA) safety is debated despite FDA findings. The CLARITY-BPA program integrates research and safety testing to provide clearer insights into BPA toxicity and human exposure risks.
Area of Science:
- Environmental Health
- Toxicology
- Regulatory Science
Background:
- Bisphenol A (BPA) is a widely used chemical with potential for daily human exposure.
- The U.S. Food and Drug Administration (FDA) previously deemed BPA safe at current exposure levels.
- Conflicting scientific and public messages regarding BPA safety persist, necessitating further investigation.
Purpose of the Study:
- To establish a research program integrating hypothesis-based investigations and guideline-compliant safety testing for BPA.
- To address ongoing debates surrounding BPA safety and provide a unified scientific assessment.
- To foster collaboration between academic researchers and regulatory agencies on BPA toxicity.
Main Methods:
- The Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA) was established.
- This program links diverse research studies with standardized safety testing protocols.
- The study design facilitates a comprehensive evaluation of BPA's toxicological profile.
Main Results:
- The paper details the study's conduct and provides a midterm progress update.
- The CLARITY-BPA program is actively collecting and analyzing data from multiple research arms.
- Initial findings are expected to inform the ongoing assessment of BPA risks.
Conclusions:
- The CLARITY-BPA program represents a significant collaborative effort to resolve BPA safety questions.
- The integrated approach aims to provide robust data for regulatory decision-making.
- Further results from the CLARITY-BPA study will be crucial for public health guidance.
